alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.1

**CHIEF EXECUTIVE OFFICER CERTIFICATION**

I, Rhett R. Atkins,President and Chief Executive Officer of Eden Bioscience Corporation, certifythat:

1.     Ihave reviewed this quarterly report on Form 10-Q of Eden BioscienceCorporation;

2.     Basedon my knowledge, this quarterly report does not contain any untrue statement ofa material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statements weremade, not misleading with respect to the period covered by this quarterlyreport;

3.     Basedon my knowledge, the financial statements, and other financial informationincluded in this quarterly report, fairly present in all material respects thefinancial condition, results of operations and cash flows of the registrant asof, and for, the periods presented in this quarterly report;

4.     Theregistrant’s other certifying officer and I are responsible for establishingand maintaining disclosure controls and procedures (as defined in Exchange ActRules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)     Designedsuch disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries,is made known to us by others within those entities, particularly during theperiod in which this quarterly report is being prepared;

b)     Evaluatedthe effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

c)     Disclosedin this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter thathas materially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and

5.     Theregistrant’s other certifying officer and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board ofdirectors (or persons performing the equivalent function):

a)     allsignificant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize andreport financial information; and

b)     anyfraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financialreporting.

Date:  November8, 2004
<PAGE>   1

                                                                    EXHIBIT 23.1


                       CONSENT OF INDEPENDENT ACCOUNTANTS

     We hereby consent to the incorporation by reference in the Registration
Statement of Lason, Inc. on Form S-8 (File Nos. 333-18551 and 333-81269) of our
report dated March 30, 2000, relating to the consolidated financial statements
and financial statement schedule of Lason, Inc. as of December 31, 1999 and
1998, and for the years ended December 31, 1999, 1998 and 1997, which appears
in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

March 30, 2000
Detroit, Michigan
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from the
Consolidated Balance Sheet and Statement of Income found on pages 32 & 33 of the
company's Form 10-K for the year ending March 31, 1999 and is qualified in its
entirety by reference to such consolidated financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              MAR-31-1999
<PERIOD-END>                                   MAR-31-1999
<CASH>                                               3,686
<SECURITIES>                                             0
<RECEIVABLES>                                        7,695
<ALLOWANCES>                                           112
<INVENTORY>                                         13,466
<CURRENT-ASSETS>                                    26,585
<PP&E>                                              25,446
<DEPRECIATION>                                       5,471
<TOTAL-ASSETS>                                      77,452
<CURRENT-LIABILITIES>                               17,155
<BONDS>                                             29,381
<PREFERRED-MANDATORY>                                    0
<PREFERRED>                                              1
<COMMON>                                                 4
<OTHER-SE>                                          30,911
<TOTAL-LIABILITY-AND-EQUITY>                        77,452
<SALES>                                             75,452
<TOTAL-REVENUES>                                    75,452
<CGS>                                               59,954
<TOTAL-COSTS>                                       67,611
<OTHER-EXPENSES>                                       280
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                   1,813
<INCOME-PRETAX>                                      5,748
<INCOME-TAX>                                         2,266
<INCOME-CONTINUING>                                  3,482
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                         3,482
<EPS-BASIC>                                         0.69
<EPS-DILUTED>                                         0.69



</TABLE>
#### Daniel W. Asher, Appellant, v Joseph J. Gigante et al., Respondents.

[800 NYS2d 642]

In an action for specific performance of an alleged oral contract for the conveyance of real property, the plaintiff appeals from an order of the Supreme Court, Nassau County (Roberto, J.), dated September 30, 2004, which, inter alia, granted the defendants’ cross motion to dismiss the complaint as barred by the statute of frauds and to vacate the notice of pendency filed against the subject property.

Ordered that the appeal is dismissed as academic, without costs or disbursements.

The plaintiff commenced this action for specific performance of an alleged oral agreement to convey certain real property to him. Although the alleged agreement was subject to the writing requirement found in General Obligations Law § 5-703 (3), the plaintiff nevertheless contended that he was entitled to specific performance based on his claim that his part performance was unequivocally referable to the alleged agreement to convey *(see*General Obligations Law § 5-703 [4]). The Supreme Court disagreed and, inter alia, granted the cross motion to dismiss the complaint and to vacate the notice of pendency filed against the subject property.

*917The plaintiff appealed but did not seek a stay of enforcement of the order pending appeal. Thereafter, during the pendency of this appeal, the subject real property was sold to a nonparty and the plaintiff concedes that the remedy sought is no longer available. Given these circumstances, the rights of the parties would not be directly affected by the resolution of this appeal, and this matter does not otherwise warrant invoking an exception to the mootness doctrine *(see Matter of Hearst Corp. v Clyne,*50 NY2d 707 [1980]; *Equicredit Corp. of Am. v Cabrero,*17 AD3d 520 [2005]). Accordingly, the appeal has been rendered academic and dismissal is appropriate *(see Romaro Corp. v Sea & Sky Garden,*304 AD2d 742 [2003]; *Matter of Congregation Bnei Yoel v Monroe-Woodbury Cent. School Dist.,*258 AD2d 582; *Matter of Vetri,*208 AD2d 755 [1994]). Cozier, J.P., S. Miller, Mastro and Rivera, JJ., concur.
<PAGE>

                        AMENDMENT TO EMPLOYMENT AGREEMENT

This Amendment to Employment Agreement ("Amendment") is made and entered into 
as of April 28, 1997, by and between Price Enterprises, Inc., a Delaware 
Corporation ("Employer") and Robert M. Gans ("Executive").

                                    RECITALS
                                    --------
    
A.  On September 20, 1994 an Employment Agreement was made and entered into 
    and between Executive and Employer.

B.  On April 11, 1996, Section 2.3 of the Employment Agreement was modified, 
    such that Executive is entitled to three weeks paid vacation each year.

C.  On July 23, 1996, Section 2.1 of the Employment Agreement was modified,
    such that Executive's annual base salary was increased to $175,000.

D.  Employer and Executive now desire to further amend the Employment 
    Agreement, as set forth hereinbelow:

                                     AGREEMENT
                                     ---------

1.  Section 3.1 of the Employment Agreement, which currently provides:

    The term of Executive's employment hereunder shall commence on October
    17, 1994 and shall continue until October 16, 1997 unless sooner 
    terminated or extended as hereinafter provided (the "Employment Term").

    is hereby amended to provide as follows:

    The term of Executive's employment hereunder shall commence on October
    17, 1994 and shall continue until October 16, 1998, unless sooner
    terminated or extended as hereinafter as provided (the "Employer Term").


<PAGE>

2.  All other terms of the Employment Agreement shall remain unaltered and 
    fully effective.

Date:  April 28, 1997

EXECUTIVE                                    EMPLOYER
---------                                    --------
                                             PRICE ENTERPRISES, INC.
Robert M. Gans                               
                                             By:    /s/ ROBERT E. PRICE
/s/ ROBERT M. GANS                                  -------------------
-----------------------                      Name:  Robert E. Price
                                                    -------------------
                                             Title: President
                                                    ------------------
# The Agricultural or Forestry Tractors (Emission of Gaseous and Particulate Pollutants) and Tractor etc (EC Type-Approval)            (Amendment) Regulations 2013 (revoked)         

        - Previous
        - Next

U.K.

Statutory Instruments

# 2013 No. 3171

Environmental Protection

Road Traffic

# The Agricultural or Forestry Tractors (Emission of Gaseous and Particulate Pollutants) and Tractor etc (EC Type-Approval) (Amendment) Regulations 2013 (revoked)F1

Made

12th December 2013

Laid before Parliament

19th December 2013

Coming into force

28th January 2014

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .                        

F1Order revoked (20.5.2018) by The Agricultural and Forestry Vehicles (Type-Approval) Regulations 2018 (S.I. 2018/236), **Sch. 2 para. 4(f)** (with reg. 1(c), Sch. 1 paras. 16, 17)
# Commission Implementing Decision of 28 April 2014 on the recognition of the legal and supervisory framework of Mexico as equivalent            to the requirements of Regulation (EC) No 1060/2009 of the European Parliament and of the Council on credit rating agencies            (Text with EEA relevance) (2014/247/EU) (repealed)         

        - Previous
        - Next

U.K.

# Commission Implementing Decision

# of 28 April 2014

# on the recognition of the legal and supervisory framework of Mexico as equivalent to the requirements of Regulation (EC) No                        1060/2009 of the European Parliament and of the Council on credit rating agencies                     

# (Text with EEA relevance)

# (2014/247/EU) (repealed)

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .                        

Textual Amendments

F1Repealed by Commission Implementing Decision (EU) 2019/1280 of 29 July 2019 on the recognition of the legal and supervisory framework                                 of Mexico as equivalent to the requirements of Regulation (EC) No 1060/2009 of the European Parliament and of the Council                                 on credit rating agencies (Text with EEA relevance.).
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED AUGUST 31, 1999 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAY-31-2000
<PERIOD-START>                             JUN-01-1999
<PERIOD-END>                               AUG-31-1999
<CASH>                                           5,094
<SECURITIES>                                         0
<RECEIVABLES>                                    2,215
<ALLOWANCES>                                       122
<INVENTORY>                                      7,714
<CURRENT-ASSETS>                                17,002
<PP&E>                                          29,729
<DEPRECIATION>                                  11,244
<TOTAL-ASSETS>                                  81,239
<CURRENT-LIABILITIES>                            7,632
<BONDS>                                         76,359
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             4
<OTHER-SE>                                     (6,799)
<TOTAL-LIABILITY-AND-EQUITY>                    81,239
<SALES>                                         13,430
<TOTAL-REVENUES>                                13,430
<CGS>                                            2,121
<TOTAL-COSTS>                                   10,951
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,924
<INCOME-PRETAX>                                (1,333)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (1,333)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,333)
<EPS-BASIC>                                     (0.53)
<EPS-DILUTED>                                   (0.53)


</TABLE>
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> BD
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-25-1998
<PERIOD-START>                             SEP-27-1997
<PERIOD-END>                               SEP-25-1998
<CASH>                                           2,143
<RECEIVABLES>                                  113,089
<SECURITIES-RESALE>                            488,381
<SECURITIES-BORROWED>                            2,144
<INSTRUMENTS-OWNED>                            169,410
<PP&E>                                           1,293
<TOTAL-ASSETS>                                 781,849
<SHORT-TERM>                                    47,225
<PAYABLES>                                     402,683
<REPOS-SOLD>                                    45,900
<SECURITIES-LOANED>                                  0
<INSTRUMENTS-SOLD>                             164,095
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           135
<OTHER-SE>                                     108,804
<TOTAL-LIABILITY-AND-EQUITY>                   781,849
<TRADING-REVENUE>                               24,239
<INTEREST-DIVIDENDS>                            36,434
<COMMISSIONS>                                   32,672
<INVESTMENT-BANKING-REVENUES>                        0
<FEE-REVENUE>                                    6,024
<INTEREST-EXPENSE>                              23,334
<COMPENSATION>                                  37,802
<INCOME-PRETAX>                                 19,698
<INCOME-PRE-EXTRAORDINARY>                      11,874
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    11,874
<EPS-PRIMARY>                                     1.05
<EPS-DILUTED>                                     1.01
        

</TABLE>
Exhibit 32.1




CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Quarterly Report
of Eden Bioscience Corporation (the Company) on Form 10-Q for the period ended June 30, 2007 as filed with the Securities and Exchange
Commission on the date hereof (the Report), I, Bradley S. Powell, President and Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:




(1)  The Report fully
complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and




(2)  The information
contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.




Date: August 10, 2007


| |  |  |  | /s/ Bradley S. Powell Bradley S. Powell President and Chief Financial Officer
| |  |  |  | -----------------------------------------------------------------------------

---
Exhibit 32.1





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002








In
connection with the Quarterly Report of Eden Bioscience Corporation (the
“Company”) on Form 10-Q for the period ended September 30, 2008 as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I,
Nathaniel T. Brown, Chief Executive Officer, Chief Financial Officer and
Secretary of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:





(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934  (15 U.S.C. 78m or 78o(d));
and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





Date:  November
      11, 2008/s/ Nathaniel T. BrownNathaniel
      T. BrownChief
      Executive Officer, Chief Financial Officer andSecretary
# Commission Implementing Decision of 7 July 2014 amending Decision 2003/467/EC as regards the declaration of Estonia as officially            enzootic-bovine-leukosis-free Member State (notified under document C(2014) 4547) (Text with EEA relevance) (2014/441/EU)         

        - Previous
        - Next

U.K.

# Commission Implementing Decision

# of 7 July 2014

# amending Decision 2003/467/EC as regards the declaration of Estonia as officially enzootic-bovine-leukosis-free Member State

# *(notified under document C(2014) 4547)*

# (Text with EEA relevance)

# (2014/441/EU)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Directive 64/432/EEC of 26 June 1964 on animal health problems affecting intra-Community trade in                           bovine animals and swine(1), and in particular point E in Chapter I of Annex D thereto,                        

Whereas:

(1)Directive 64/432/EEC applies to trade within the Union in bovine animals and swine. It lays down the conditions whereby a                              Member State or region of a Member State may be declared officially enzootic-bovine-leukosis-free as regards bovine herds.

(2)Annex III to Commission Decision 2003/467/EC(2) lists the Member States and regions thereof which are declared officially enzootic-bovine-leukosis -free.

(3)Estonia has submitted to the Commission documentation demonstrating compliance with the conditions for the officially enzootic-bovine-leukosis-free                              status laid down in Directive 64/432/EEC for its whole territory.

(4)Following the evaluation of the documentation submitted by Estonia, that Member-State should be declared officially enzootic-bovine-leukosis-free.

(5)Annex III to Decision 2003/467/EC should therefore be amended accordingly.

(6)The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain                              and Animal Health,

HAS ADOPTED THIS DECISION:

# Article 1U.K.

Annex III to Decision 2003/467/EC is amended in accordance with the Annex to this Decision.

# Article 2U.K.

This Decision is addressed to the Member States.

Done at Brussels, 7 July 2014.

*For the Commission*                            

Tonio Borg                            

*Member of the Commission*                            

## ANNEXU.K.

In Annex III to Decision 2003/467/EC, Chapter 1 is replaced by the following:

### ‘CHAPTER 1U.K.**Officially enzootic-bovine-leukosis-free Member States**

1

OJ 121, 29.7.1964, p. 1977/64.                           

2

Commission Decision 2003/467/EC of 23 June 2003 establishing the official tuberculosis, brucellosis and enzootic-bovine-leukosis-free                              status of certain Member States and regions of Member States as regards bovine herds (OJ L 156, 25.6.2003, p. 74).
II 

110TH CONGRESS 

2D SESSION S. 3357 

To extend the temporary suspension of duty on certain rayon staple fibers. 

IN THE SENATE OF THE UNITED STATES 

JULY 29 (legislative day, JULY 28), 2008 

Ms. COLLINS introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on certain rayon 

staple fibers. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. CERTAIN RAYON STAPLE FIBERS. 

4 (a) IN GENERAL.—Heading 9902.55.04 of the Har5 monized Tariff Schedule of the United States is amend6 ed— 

7 (1) by striking the date in the effective period 

8 column and inserting ‘‘12/31/2011’’; and 

9 (2) by striking the ‘‘Free’’ in the column 1 gen10 eral rate of duty column and inserting ‘‘1.9%’’. 


smartinez on PROD1PC64 with BILLS
2 

•S 3357 IS

1 (b) EFFECTIVE DATE.—The amendments made by 

2 this section apply with respect to goods entered, or with3 drawn from warehouse for consumption, on or after the 

4 15th day after the date of the enactment of this Act. 

Æ 


smartinez on PROD1PC64 with BILLS